# OnCo record cto1681 (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/cto1681/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "cto1681" ;
  schema:name "CTO1681"@en ;
  schema:alternateName "GP1681"@en ;
  schema:description "CTO1681 is a tablet from CytoAgents meant to prevent and treat cytokine release syndrome, an immune over-reaction that can follow CAR-T cell therapy for blood cancers."@en ;
  schema:url <https://onco.cc/drugs/cto1681/> ;
  schema:dateModified "2026-11-04"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT05905328>, <https://reporter.nih.gov/project-details/11418976> ;
  onco:status "phase-2" ;
  onco:tag "pipeline" ;
  onco:modality "Oral small molecule" ;
  onco:companies <https://onco.cc/companies/cytoagents/> ;
  onco:terms <https://onco.cc/terms/crs/> .